Last Posted: Feb 28, 2020
- The Case for Remedial Germline Editing—The Long-term View
EY Adashi et al, JAMA Health Forum, Ferbuary 27, 2020 - Hacking the Cancer Genome: Profiling Therapeutically Actionable Long Non-coding RNAs Using CRISPR-Cas9 Screening.
Esposito Roberta et al. Cancer cell 2019 35(4) 545-557 - Therapeutic genome editing in cardiovascular diseases.
Nishiga Masataka et al. Advanced drug delivery reviews 2020 Feb - Molecular Therapies for Inherited Retinal Diseases-Current Standing, Opportunities and Challenges.
Vázquez-Domínguez Irene et al. Genes 2019 10(9) - Super-precise CRISPR tool enhanced by enzyme engineering: Improvements to a method known as base editing could pave the way for safer gene therapies.
H Ledford, Nature, February 11, 2020 - CRISPR takes on cancer
J Couzin-Frankel, Science, February 7, 2020 - Step aside CRISPR, RNA editing is taking off: Making changes to the molecular messengers that create proteins might offer flexible therapies for cancer, pain or high cholesterol, in addition to genetic disorders.
S Reardon, Nature, February 4, 2020 - Prime Time for Genome Editing?
Urnov Fyodor D et al. The New England journal of medicine 2020 01 (5) 481-484 - Genome Editing for Mucopolysaccharidoses.
Poletto Edina et al. International journal of molecular sciences 2020 Jan 21(2) - Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
Li Hongyi et al. Signal transduction and targeted therapy 2020 1
.png)
No hay comentarios:
Publicar un comentario